UB CAT

The UB CAT program.

The University at Buffalo Center for Advanced Technology in Big Data and Health Sciences (UB CAT) is a project cost-sharing grant program funded by Empire State Development, and designed to drive the growth of life and health science businesses in New York State.

By partnering with a University at Buffalo investigator, New York State companies can access matching funds for collaborative product development or proof of concept research in the health sciences, especially in the areas of drug development, medical devices, diagnostic tools and healthcare IT. Preference will be given to projects that involve or enable Big Data applications.

Health science companies can benefit from: project cost-sharing; outstanding faculty expertise; state-of-the art facilities and equipment; and access to SUNY’s reduced rates on services and supplies.

Eligibility Criteria for Project Funding:

  • Proposed projects must align with UB CAT’s focus areas 
    (big data and health sciences)
  • Company is registered in NYS and has an office location in NYS
  • Company has at least 1 full time employee
  • Company has available matching funds for project cost sharing
  • Commitment of a University at Buffalo Principal Investigator*
  • Scientific, technical, and innovative merit
  • Demonstrated need for support of project
  • Ability to successfully complete project in one fiscal year
    (July-June of the project year)
  • Potential economic impact for New York State**
  • Appropriateness of budget items within UB CAT project guidelines

* All projects are subject to State University of New York intellectual property policies. Click here for special SWIFT for CAT preferred terms.

** Companies that receive CAT funding are required to provide annual economic impact reports for five years. Information on eligible economic impacts and reporting is available upon request.

APPLY FOR FUNDING


STEP 1: Companies are invited to submit a Letter of Intent by March 1, 2021. 

STEP 2: Preselected companies are invited to submit a full application (deadline April 15, 2021).

Download Letter of Intent Template →

Current UB CAT Projects:

Current UB CAT projects where faculty and industry have partnered for 2020-2021:

Jun Qu, PhD
Epigenetic Drug Discovery Platform for Methylation Inhibitors

Albert Titus, PhD
Wireless Biosensor System Advancement Project

Dhaval K Shah, PhD
Pharmacological Assessment of AI-Designed Novel Nanobodies for the Treatment of SARS-CoV-2, Variants of SARS-CoV-2, and Future SARS Viruses

Scott Nodzo, MD
Antimicrobial Electrical Stimulation in Swine Knee Model

Mark Ehrensberger, PhD
Live Microbe Imaging of Antimicrobial Electrical Stimulation
Electrical Stimulation Effects on Osseointegration

Immune Modulatory Therapies

Richard Bankert, VMD, PhD
Development and implementation of analytic methods and modeling of big datasets for certain proprietary small molecules in cancer immunotherapy

Neurovascular Diagnostics

John Kolega, PhD
Molecular Biomarkers of Dangerous Intracranial Aneurysms

Praveen Arany, DDS, PhD
Preclinical Optimization and Clinical Testing of Novel Oral Health Products

Pro Al Medico

Brian R. Weil, PhD
T3np Neuroprotection Following Cardiac Arrest

Rheonix

Michael Buck, PhD
Automated DNA Library Prep for NGS

You First Services

Francine Battaglia, PhD
Simulations for the Containment and Control of COVID-19 in Indoor Spaces with the SteriSpaceā„¢ Air Sterilization System

Veronomics

Jianxin Wang, PhD
Genomics/Bioinformatics Platforms to Identify Cancer Drugs

APPLY FOR FUNDING


STEP 1: Companies are invited to submit a Letter of Intent by March 1, 2021. 

STEP 2: Preselected companies are invited to submit a full application (deadline April 15, 2021).

Download Letter of Intent Template →